关注
Chengappa Kavadichanda
Chengappa Kavadichanda
Consultant, RheumaCARE, Mysuru
在 rheumacare.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
S Shah, D Danda, C Kavadichanda, S Das, MB Adarsh, VS Negi
Rheumatology International 40 (10), 1539-1554, 2020
1462020
Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States
R Raiker, C DeYoung, H Pakhchanian, S Ahmed, C Kavadichanda, ...
Seminars in arthritis and rheumatism 51 (5), 1057-1066, 2021
872021
Deficiency of adenosine deaminase 2 in adults and children: experience from India
A Sharma, G Naidu, V Sharma, S Jha, A Dhooria, V Dhir, P Bhatia, ...
Arthritis & Rheumatology 73 (2), 276-285, 2021
542021
Lupus retinopathy: a marker of active systemic lupus erythematosus
G Seth, KG Chengappa, DP Misra, R Babu, P Belani, KC Shanoj, ...
Rheumatology international 38 (8), 1495-1501, 2018
522018
Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B*27 Connection
CG Kavadichanda, J Geng, SN Bulusu, VS Negi, M Raghavan
Frontiers in immunology 12, 601518, 2021
492021
Tele-rheumatology for overcoming socioeconomic barriers to healthcare in resource constrained settings: lessons from COVID-19 pandemic
C Kavadichanda, S Shah, A Daber, D Bairwa, A Mathew, S Dunga, ...
Rheumatology 60 (7), 3369-3379, 2021
452021
Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: observations from an Indian inception cohort
M Rathi, P Singh, HP Bi, A Shivanna, C Kavadichanda, SR Tripathy, ...
Lupus 30 (1), 158-164, 2021
302021
Short term outcomes of COVID-19 in lupus: propensity score matched analysis from a nationwide multi-centric research network
R Raiker, H Pakhchanian, C DeYoung, L Gupta, S Kardeş, S Ahmed, ...
Journal of Autoimmunity 125, 102730, 2021
272021
Characterization of cell-derived microparticles in synovial fluid and plasma of patients with rheumatoid arthritis
BNR Michael, V Kommoju, C Kavadichanda Ganapathy, VS Negi
Rheumatology International 39 (8), 1377-1387, 2019
222019
APLAR recommendations on the practice of telemedicine in rheumatology
S Ahmed, R Grainger, A Santosa, A Adnan, KA Alnaqbi, YH Chen, ...
International Journal of Rheumatic Diseases 25 (3), 247-258, 2022
212022
Clinical correlates of HLA‐B* 27 and its subtypes in enthesitis‐related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients
CG Kavadichanda, G Seth, G Kumar, R Gulati, VS Negi
International journal of rheumatic diseases 22 (7), 1289-1296, 2019
192019
Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network
R Raiker, H Pakhchanian, C Kavadichanda, L Gupta, S Kardeş, S Ahmed
Clinical rheumatology, 1-10, 2022
182022
De Novo Crohn's disease triggered after COVID-19: is COVID-19 more than an infectious disease?
K Senthamizhselvan, R Ramalingam, P Mohan, C Kavadichanda, ...
ACG Case Reports Journal 8 (8), e00652, 2021
182021
Systemic lupus erythematosus and overlap: A clinician perspective
S Shah, KG Chengappa, VS Negi
Clinical Dermatology Review 3 (1), 12-17, 2019
182019
Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients
A Fierabracci, A Arena, F Toto, N Gallo, A Puel, M Migaud, M Kumar, ...
Journal of Endocrinological Investigation 44, 661-677, 2021
152021
Management of Takayasu arteritis
DP Misra, K Singh, U Rathore, CG Kavadichanda, M Ora, N Jain, ...
Best Practice & Research Clinical Rheumatology 37 (1), 101826, 2023
142023
Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study
SK Dunga, C Kavadichanda, L Gupta, R Naveen, V Agarwal, VS Negi
Rheumatology International 42 (7), 1155-1165, 2022
142022
Multiple drug intolerance syndrome: an underreported distinct clinical entity
SK Behera, S Das, KG Chengappa, AS Xavier, S Selvarajan
Current Clinical Pharmacology 14 (2), 84-90, 2019
142019
COVID-19 outcomes in patients with dermatomyositis: a registry-based cohort analysis
H Pakhchanian, H Khan, R Raiker, S Ahmed, C Kavadichanda, M Abbasi, ...
Seminars in arthritis and rheumatism 56, 152034, 2022
132022
Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
A Tomelleri, R Padoan, CG Kavadichanda, A Jose, K Singh, L Iorio, ...
Rheumatology 62 (10), 3427-3432, 2023
102023
系统目前无法执行此操作,请稍后再试。
文章 1–20